Ruthenium-106 ocular surface brachytherapy for incompletely excised conjunctival melanoma and squamous cell carcinoma
{{output}}
Purpose: To examine the efficacy and safety of ruthenium-106 (106Ru) ocular surface brachytherapy for incompletely excised conjunctival melanoma (CM) and conjunctival squamous cell carcinoma (CSCC) patients, with no adjunctive tr... ...
